Bespoke Extracts (BSPK) Change in Receivables (2018 - 2025)
Bespoke Extracts' (BSPK) quarterly Change in Receivables came in at $2525.0 in Q3 2025, up 119.27% year-on-year from $1151.5 in Q3 2024, and down 96.07% quarter-over-quarter from $64250.0 in Q2 2025.
Bespoke Extracts (BSPK) Change in Receivables (2018 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Change in Receivables across 8 years of filings, most recently posting $2525.0 for Q3 2025.
- Change in Receivables for Q3 2025 came in at $2525.0, up 119.27% year-over-year; the trailing twelve-month figure through Sep 2025 was $57449.0 (up 43094.74% YoY), and the FY2024 annual result was $12050.0, down 73.36% from the prior year.
- Change in Receivables came in at $2525.0 for Q3 2025 at Bespoke Extracts, down from $64250.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $64250.0 in Q2 2025 to a low of -$36627.0 in Q2 2023.
- The 5-year median for Change in Receivables is $293.0 (2021), against an average of $6213.5.
- Peak annual rise in Change in Receivables reached 72529.69% in 2023, while the deepest fall reached 16398.65% in 2023.
- Bespoke Extracts' Change in Receivables stood at -$588.0 in 2021, then jumped by 62.24% to -$222.0 in 2022, then slumped by 226.13% to -$724.0 in 2023, then soared by 1645.99% to $11193.0 in 2024, then slumped by 77.44% to $2525.0 in 2025.
- The last three Change in Receivables figures came in at $2525.0 (Q3 2025), $64250.0 (Q2 2025), and -$20519.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | 2,525.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,525.00 |
| Sep 30, 2025 | 2,525.00 |
| Jun 30, 2025 | 64,250.00 |
| Jun 30, 2025 | 64,250.00 |
| Mar 31, 2025 | -20,519.00 |
| Mar 31, 2025 | -20,519.00 |
| Dec 31, 2024 | 11,193.00 |
| Dec 31, 2024 | 11,193.00 |
| Sep 30, 2024 | -13,102.00 |
| Sep 30, 2024 | -13,102.00 |
| Jun 30, 2024 | 16,060.00 |
| Jun 30, 2024 | 16,060.00 |
| Mar 31, 2024 | -2,101.00 |
| Mar 31, 2024 | -2,101.00 |
| Dec 31, 2023 | -724.00 |
| Dec 31, 2023 | -724.00 |
| Sep 30, 2023 | 36,094.00 |
| Sep 30, 2023 | 36,094.00 |
| Jun 30, 2023 | -36,627.00 |
| Jun 30, 2023 | -36,627.00 |